Tamiflu 75 mg 10 capsules
Plaquenil 200 mg 60 tablets
Cerebrolysin 5 ml 5 vials
Hypoxen 250 mg 30 capsules
Sildenafil 100 mg 20 tablets
Prednisolone 5mg 100 tablets
Ingavirin 90 mg 10 capsues
Ovestin 2 mg 30 tablets
Ovestin Vaginal cream 15g
Macmiror 200 mg 20 tablets
Ventolin nebula 20 ampoules
- Antibacterial medication
- Antifungal medication
- Antiviral Medication
- Cardiovascular medication
- different medication
- Hormonal medication
- Immunosuppressants and immunomodulating medications
- Nervous system
- Pain relievers and anti-inflammatory
- Respiratory system
- Treatment of diseases of the liver and gastrointestinal tract
- Treatment of sensory organs, eyesight and hearing
- Urogenital system
Piracetam 800 mg 30 tablets
De-Nol 120mg 112 tablets
De-Nol 120mg 56 tablets
De-Nol 120mg 32 tablets
finasteride 5mg 30 tablets
Itrazole 100 mg 42 capsules
furasol 15 sachets of 100 mg
Triacort OINTMENT 0.1% 10G
Urseptia 200 mg 20 capsules
Minolexin 50 mg 20 capsules
Immard 200 mg 30 tablets
Adenuric 120 mg 28 tablets
Champix 1 mg 112 tablets
Madopar 125 mg 100 capsules
encephabol 100 mg 50 tablets
Donormil 30 tablets
Mexidol 2 ml 10 vials
Novo-passit 10 tablets
Cerebrolysin 10 ml 5 vials
Mexicor 100 mg 20 capsules
Combilipen 30 tablets
Cavinton 5 ml 10 vials
Neurontin 300 mg 50 capsules
Actovegin 2 ml 25 vials
Dobrokam 250 mg 30 tablets
neyrobion 3 ml 3 vials
Sermion 10 mg 50 tablets
Piracetam 400 mg 60 tablets
Vasobral 30 tablets
Persen night 20 capsules
Vestibo 16 mg 30 tablets
Tidomet forte 100 tablets
Tebantin 300 mg 50 capsules
Micardis 80 mg 28 tablets
Manufacturer: Boehringer Ingelheim
Country of origin: Greece
General Description: An antihypertensive drug, an angiotensin II receptor blocker + diuretic
Pharmacological action
Antihypertensive drug.
Pharmacodynamics
Telmisartan is a specific antagonist of angiotensin II receptors. Has a high affinity for the AT1 receptor subtype of angiotensin II, through which the action of angiotensin II is realized. Telmisartan displaces angiotensin II from its binding to the receptor, without the action of an agonist for this receptor. It only binds to the AT1 receptor subtype of angiotensin II. Binding is long-lasting. Telmisartan does not have an affinity for other receptors (including AT2 receptors) and other less studied angiotensin receptors. The functional significance of these receptors, as well as the effect of their possible excessive stimulation with angiotensin II, whose concentration increases with the appointment of telmisartan, have not been studied. Reduces the concentration of aldosterone in the blood, does not inhibit renin in the blood plasma and does not block the ion channels. It does not inhibit ACE (kininase II), an enzyme that also breaks down bradykinin, so the increase in side effects caused by bradykinin is not expected.
Telmisartan at a dose of 80 mg completely blocks the hypertensive effect of angiotensin II. The onset of hypotensive action is noted within 3 hours after the first administration of telmisartan. The effect of the drug persists for 24 hours and remains significant until 48 hours. The pronounced antihypertensive effect usually develops after 4-8 weeks of regular administration.
In patients with arterial hypertension telmisartan reduces systolic and diastolic blood pressure, without affecting the heart rate.
In the case of a sharp withdrawal of telmisartan, blood pressure gradually returns to the baseline without the development of withdrawal syndrome.
Indications
- arterial hypertension;
- Reduction of cardiovascular morbidity and mortality in patients aged 55 years and older with a high risk of cardiovascular disease.


.